Cargando…

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells

Mostrar otras versiones (1)

T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor family–related protein (GITR) can evoke effective tumor immunity. A single administration of agonistic anti-GITR monoclonal antibody (mAb) to tumor-bearing mice intravenously or directly into tumors provoked potent tumor-sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Kuibeom, Yamazaki, Sayuri, Nakamura, Kyoko, Nishioka, Tomohisa, Hirota, Keiji, Yamaguchi, Tomoyuki, Shimizu, Jun, Nomura, Takashi, Chiba, Tsutomu, Sakaguchi, Shimon
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2005
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213162/ https://www.ncbi.nlm.nih.gov/pubmed/16186187 http://dx.doi.org/10.1084/jem.20050940

Ejemplares similares

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells
por: Ko, Kuibeom, et al.
Publicado: (2012)

Immunologic Self-Tolerance Maintained by Cd25(+)Cd4(+)Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4
por: Takahashi, Takeshi, et al.
Publicado: (2000)

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17(+) Th cells that cause autoimmune arthritis
por: Hirota, Keiji, et al.
Publicado: (2007)

The thymic medulla is required for Foxp3(+) regulatory but not conventional CD4(+) thymocyte development
por: Cowan, Jennifer E., et al.
Publicado: (2013)

CD8(+) T Cells: GITR Matters
por: Ronchetti, Simona, et al.
Publicado: (2012)

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells
por: Nishikawa, Hiroyoshi, et al.
Publicado: (2005)

TGF-β1 maintains suppressor function and Foxp3 expression in CD4(+)CD25(+) regulatory T cells
por: Marie, Julien C., et al.
Publicado: (2005)

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
por: Hirota, Keiji, et al.
Publicado: (2007)

GITR Activation Induces an Opposite Effect on Alloreactive CD4(+) and CD8(+) T Cells in Graft-Versus-Host Disease
por: Muriglan, Stephanie J., et al.
Publicado: (2004)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
por: Capuano, Cristina, et al.
Publicado: (2021)

Complement drives Th17 cell differentiation and triggers autoimmune arthritis
por: Hashimoto, Motomu, et al.
Publicado: (2010)

Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
por: M.Gaspal, Fabrina, et al.
Publicado: (2011)

CD4(+)FoxP3(+) regulatory T cells confer infectious tolerance in a TGF-β–dependent manner
por: Andersson, John, et al.
Publicado: (2008)

Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
por: Kim, Soseul, et al.
Publicado: (2014)

In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
por: Webster, Kylie E., et al.
Publicado: (2009)

VEGF-A modulates expression of inhibitory checkpoints on CD8(+) T cells in tumors
por: Voron, Thibault, et al.
Publicado: (2015)

Homeostatic maintenance of natural Foxp3 (+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
por: Setoguchi, Ruka, et al.
Publicado: (2005)

LPS combined with CD47mAb enhances the anti‑osteosarcoma ability of macrophages
por: Yuan, Peng, et al.
Publicado: (2023)

In vitro up-regulation of expression of GITR on human CD8+ cells
por: Thanavala, Yasmin
Publicado: (2009)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)

The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
por: Goda, Noriko, et al.
Publicado: (2022)

IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25(+)Foxp3(-) T cells
por: Tomala, Jakub, et al.
Publicado: (2021)

Anti-CD137 mAb Deletes Both Donor CD4(+) and CD8(+) T Cells in Acute Graft-versus-host Disease
por: Kim, Juyang, et al.
Publicado: (2011)

Expansion of regulatory GITR(+)CD25(low/-)CD4(+) T cells in systemic lupus erythematosus patients
por: Nocentini, Giuseppe, et al.
Publicado: (2014)

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
por: Zhang, Jingzhe, et al.
Publicado: (2019)

Complement system in Anti-CD20 mAb therapy for cancer: A mini-review
por: Gao, Yiwen
Publicado: (2023)

A functionally specialized population of mucosal CD103(+) DCs induces Foxp3(+) regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism
por: Coombes, Janine L., et al.
Publicado: (2007)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells
por: Gattinoni, Luca, et al.
Publicado: (2005)

Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020)

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014)

Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity
por: Li, Hua-Fei, et al.
Publicado: (2015)

Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
por: Mohanty, Suchismita, et al.
Publicado: (2019)

GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
por: Durham, Nick M., et al.
Publicado: (2017)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

CD3(+), CD8(+), CD4(+) and FOXP3(+) T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
por: Hiltunen, Niko, et al.
Publicado: (2021)

Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
por: Guo, Dan, et al.
Publicado: (2020)

Restoration of CD28 Expression in CD28(−) CD8(+) Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
por: Topp, Max S., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_i4cgp6ht0ib3qh78m7cmnv531s